“‘…I decided I would buy a used VW Rabbit. So, [before the IPO] I sold, i think, eight hundred shares for eight thousand dollars…After we went public, the stock price went up and up and up. At some point, those eight hundred shares were worth a million dollars. And I bought a used Rabbit for that, a million dollar Rabbit. Oh god!'”-Axel Ullrich, page 159
In the tumultuous world of Wall Street, anything could happen. Sometimes, the most unlikely companies rise to the top, multiplying in size and net worth over a very short period of time. In Chapter 6 of Genentech, we see Genentech go through such a transformation. Most of us remember this kind of growth happening in companies like Apple, Facebook, and Google as we were growing up. Wall Street continues to be a risky environment today, where budding companies “make it big or die trying”. However, Genentech’s success in this chapter seems unique, in that there was great interest in it before it had a product on the market. The company had no Macintosh or iPhone to sell, no social network making millions off ad revenue and growing exponentially every month. Genentech had nothing to sell, yet it had millions of investors interested in its future because of the innovative biotech the company was researching and the amazing applications that things like man-made insulin and HGH could have.
I think that Genentech’s success as an IPO is a sort of Cinderella story which shows the advantages of speculation and investment in a time when many of us are highly critical of Wall Street and what it does. While many will write off Wall Street investors as sharks looking for a quick buck to take from someone else, they actually have some amazing effects on our economy. They help keep money flowing into smaller businesses and help them grow into massive companies that hopefully do something good for our society. The amazing stimulative power of Wall Street is a major part of the success of almost every tech company. While the success of these companies (and also Genentech) is never guaranteed, I believe that those who invest in their risky excursions ultimately help the world become a better place.
“Genentech and the origins of biotech were far more than the successful industrial application of a novel technology. A concentration of political, social, and economic factors and strategic, scientific, financial, and business decisions molded, shaped, stymied, and encouraged Genentech’s rise to the temporary pinnacle of its stock market debut.”- Hughes, page 164